Sirio Pharma Co., Ltd. (SHE:300791)
China flag China · Delayed Price · Currency is CNY
21.25
-0.19 (-0.89%)
Apr 17, 2026, 3:04 PM CST

Sirio Pharma Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Apr '26 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20
6,5026,1676,2936,6377,51311,035
Market Cap Growth
0.84%-2.01%-5.18%-11.66%-31.92%123.46%
Enterprise Value
7,6987,1867,0626,0797,01410,638
Last Close Price
21.2519.8219.4420.3922.7533.20
PE Ratio
18.7718.9722.3931.2632.4142.88
Forward PE
26.7315.1319.62---
PS Ratio
1.461.461.762.653.175.34
PB Ratio
2.362.342.452.462.955.06
P/TBV Ratio
3.833.954.422.813.385.88
P/FCF Ratio
31.5239.83-43.90-114.44
P/OCF Ratio
9.3510.8816.3014.9222.0134.53
EV/Sales Ratio
1.731.711.972.422.965.15
EV/EBITDA Ratio
12.3311.7411.8316.5718.4930.09
EV/EBIT Ratio
17.6916.7418.7725.0624.9538.85
EV/FCF Ratio
37.3246.41-40.21-110.32
Debt / Equity Ratio
0.620.610.530.350.340.02
Debt / EBITDA Ratio
2.732.482.162.502.270.10
Debt / FCF Ratio
8.2710.38-6.20-0.36
Net Debt / Equity Ratio
0.400.310.24-0.28-0.15-0.30
Net Debt / EBITDA Ratio
1.871.361.03-2.05-0.98-1.85
Net Debt / FCF Ratio
5.345.36-9.36-4.982.03-6.80
Asset Turnover
0.800.790.760.630.730.83
Inventory Turnover
5.566.017.007.366.345.97
Quick Ratio
1.351.821.884.624.882.59
Current Ratio
1.892.452.575.185.763.42
Return on Equity (ROE)
10.94%10.83%9.12%8.09%9.81%12.47%
Return on Assets (ROA)
4.87%5.02%5.01%3.79%5.43%6.83%
Return on Invested Capital (ROIC)
10.04%11.49%12.90%9.94%12.54%14.22%
Return on Capital Employed (ROCE)
9.10%9.20%8.50%6.50%8.10%12.10%
Earnings Yield
5.31%5.27%4.47%3.20%3.09%2.33%
FCF Yield
3.17%2.51%-1.04%2.28%-2.44%0.87%
Dividend Yield
2.35%2.52%3.35%1.01%1.04%0.71%
Payout Ratio
49.89%67.56%29.83%35.84%31.29%10.05%
Buyback Yield / Dilution
-0.24%0.36%0.82%4.47%-5.00%-23.77%
Total Shareholder Return
2.11%2.88%4.17%5.49%-3.96%-23.06%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.